
carbowemb 150mg\15ml injection
Salt Composition: Carboplatin Injection
Expiry Date: 01/2028
Inclusive of all taxes
1 vial(s)
About The Product
Chemotherapy drugs, Ovaries Cancer, Lung cancer
Description
Carbowemb 150mg\15ml injection is an anti neoplastic medication. It is used in the treatment of Ovarian Cancers and Small-Cell Lung Cancer.
Carbowemb 150mg\15ml injection contains Carboplatin as its active ingredient that work against the cancer.
Common Side Effects
- The side effects of Carbowemb 150mg\15ml injection can vary from mild to extreme, affecting different parts of the body.
- Consult your doctor if symptoms persist for longer period of time. ● Weakness ● Anemia ● Low White Blood Cell Count ● Nausea ● Low Platelet Count ● Mouth Sores ● Irritation ● Burning Sensation ● Numbness ● Tingling in Hands ● Serious Infections ● Allergic Reactions ● Kidney Damage or Failure ● Severe Bleeding or Hemorrhage ● Neuro toxicity ● Hearing loss ● Serious Electrolyte Balance
Dosage And Administration
- Carbowemb 150mg\15ml injection dosage may vary based on the type of cancer being treated, the kidney's function and overall health status.
- The exact dosing is individualised.
- Dosing cycle repeats every 3-4 weeks to allow recovery from side effects.
- Carbowemb 150mg\15ml injection is administered intravenously slowly over 15-60 minutes.
- Consult your doctor for exact dosage and treatment schedule.
Mechanism Of Action
Carbowemb 150mg\15ml injection contains Carboplatin as its active ingredient that work against the cancer.
It mainly works by binding to DNA of cancer cell, disrupting their genetic structure.Therefore, preventing its further growth and proliferation in the body, ultimately leading to cell death.
Safety Advice
Faqs
Carbowemb 150mg\15ml injection majorly treats Ovarian Cancer as well as Small Cell Lung Cancer.
References
• BUCKINGHAM, R., FITT, J., & SITZIAZ, J. (1997).
Patients' experiences of chemotherapy: side‐effects of carboplatin in the treatment of carcinoma of the ovary. European journal of cancer care, 6(1), 59-71. • Oun, R., Moussa, Y.
E., & Wheate, N. J.
(2018). The side effects of platinum-based chemotherapy drugs: a review for chemists.
Dalton transactions, 47(19), 6645-6653. • Yarbro, C. H.
(1989, May). Carboplatin: A clinical review.
In Seminars in oncology nursing (Vol. 5, No.
2, pp. 63-69).
WB Saunders. • Wagstaff, A. J., Ward, A., Benfield, P., & Heel, R.
C. (1989).
Carboplatin: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer. Drugs, 37(2), 162-190.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75)
